MedicalCV Elects Susan L. Critzer Chairperson of the Board.

MINNEAPOLIS -- MedicalCV, Inc. (OTC Bulletin Board: MDCV), www.medcvinc.com, a cardiovascular surgery device manufacturer which utilizes a laser-based technology platform for cardiac tissue ablation and focuses on the surgical needs surrounding atrial fibrillation, announced today that Susan L.

Ms. Critzer, one of the Company's directors since August 2002, has over 25 years of industry experience in general management, operations and product development. Ms. Critzer served as Chief Executive Officer and Chief Financial Officer of Restore Medical, Inc., a company focused on developing and marketing products for the ear, nose and throat field, from June 2002 to April 2005. From January 2001 to June 2002, Ms. Critzer served as Chief Operating Officer of Venturi Development Group, the business incubator focused on seed level medical device opportunities which founded Restore Medical. Prior to joining Venturi, Ms. Critzer served as President and Chief Executive Officer and Acting Chief Financial Officer of Integ Incorporated, a publicly held development stage glucose monitoring company from 1998 until it was acquired by Inverness Medical in early 2001. She joined Integ in 1995 as Vice President, Operations. Before joining Integ, Ms. Critzer served in various management roles at the Davis + Geck Division of American Cyanamid Corp., and the Deseret Medical Division of Becton-Dickinson Corp. Ms. Critzer began her career with General Motors Corporation where she spent thirteen years in a variety of engineering and management positions, including managing a $200 million truck front suspension plant in Detroit. Ms. Critzer serves on the Board of Governors and is a 3M Fellow at the University of St. Thomas School of Engineering in St. Paul, Minnesota.

Marc P. Flores, President and CEO of MedicalCV, Inc., said "We are pleased that Sue has accepted the position of Chairperson of the Board. On behalf of company management, we look forward to working with her as we continue our product development. We also want to thank Larry Horsch for his leadership as Chairman of the Board, and are pleased that Larry will continue to serve as a director of our company."

About MedicalCV, Inc.

MedicalCV, Inc., a cardiovascular surgery device manufacturer, focuses on the development and introduction of products designed to improve patient outcomes through the early treatment of cardiovascular disorders and disease specifically, products used by cardiac surgeons to ablate cardiac tissue as a potential means to treat atrial fibrillation. The Company's core technology is the AtriLaze(TM) Surgical Ablation System for use in cardiac tissue ablation procedures. The Company acquired this technology in August 2003 and received its FDA 510(k) clearance in December 2004. The Company's common stock is traded on the OTC Bulletin Board under the symbol "MDCV."

For further information on MedicalCV, Inc., please visit www.medcvinc.com.

You may register to receive MedicalCV's future press releases and to be added to the Company's distribution list by visiting: http://www.roiny.com/form.php.